$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Thermoreversible Pluronic ® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies 원문보기

International journal of nanomedicine, v.6, 2011년, pp.151 - 166  

Nie, Shufang (Department of Pharmaceutical Engineering, Wuhan Bioengineering Institute, Yangluo Economic Development Zone, Wuhan, People's Republic of China) ,  Hsiao, WL Wendy (School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, People's Republic of China) ,  Pan, Weisan (Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People's Republic of China) ,  Yang, Zhijun (School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, People's Republic of China)

Abstract AI-Helper 아이콘AI-Helper

PurposeTo develop an in situ gel system comprising liposome-containing paclitaxel (PTX) dispersed within the thermoreversible gel (Pluronic® F127 gel) for controlled release and improved antitumor drug efficiency.MethodsThe dialysis membrane and membrane-less diffusion method were used to invest...

주제어

참고문헌 (75)

  1. 1 Schiff PB Fant J Horwitz SB Promotion of microtubule assembly in vitro by Taxol Nature 1979 277 665 667 423966 

  2. 2 Tishler RB Geard CR Hall EJ Schiff PB Taxol sensitizes human astrocytoma cells to radiation Cancer Res 1992 52 3495 3497 1350755 

  3. 3 Mekhail TM Markman M Paclitaxel in cancer therapy Expert Opin Pharmacother 2002 3 755 766 12036415 

  4. 4 Jang SH Wientjes MG Au JL Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule J Pharmacol Exp Ther 2001 296 1035 1042 11181938 

  5. 5 Au JL Li D Gan Y Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention Cancer Res 1998 58 2141 2148 9605758 

  6. 6 Raymond E Hanauske A Faivre S Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units Anticancer Drugs 1997 8 379 385 9180392 

  7. 7 Beijnen JH Beijnen-Bandhoe AU Dubbelman AC van Gijn R Underberg WJ Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids J Parenter Sci Technol 1991 45 108 112 2051255 

  8. 8 Feng S Huang G Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers J Control Release 2001 71 53 69 11245908 

  9. 9 Yeh MK Coombes AGA Jenkins PG A novel emulsification-solvent extraction technique for production of protein loaded biodegradable microparticles for vaccine and drug delivery J Control Release 1995 33 437 445 

  10. 10 Yang T Choi MK Cui FD Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome J Control Release 2007 120 169 177 17586082 

  11. 11 Yang T Cui FD Choi MK Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation Int J Pharm 2007 338 317 326 17368984 

  12. 12 Wei Z Hao J Yuan S Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization Int J Pharm 2009 376 176 185 19409463 

  13. 13 Shin HC Alani AW Rao DA Rockich NC Kwon GS Multidrug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs J Control Release 2009 140 294 300 19409432 

  14. 14 Huh KM Min HS Lee SC Lee HJ Kim S Park K A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel J Control Release 2008 126 122 129 18155795 

  15. 15 Seow WY Xue JM Yang YY Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles Biomaterials 2007 28 1730 1740 17182095 

  16. 16 Nornoo AO Chow DS Cremophor-free intravenous microemulsions for paclitaxel: II. Stability, in vitro release and pharmacokinetics Int J Pharm 2008 349 117 123 17869458 

  17. 17 Nornoo AO Zheng H Lopes LB Johnson-Restrepo B Kannan K Reed R Oral microemulsions of paclitaxel: In situ and pharmacokinetic studies Eur J Pharm Biopharm 2009 71 310 317 18793723 

  18. 18 Kan P Chen ZB Lee CJ Chu IM Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system J Control Release 1999 58 271 278 10099152 

  19. 19 Lee IH Park YT Roh K Chung H Kwon IC Jeong SY Stable paclitaxel formulations in oily contrast medium J Control Release 2005 102 415 425 15653161 

  20. 20 Bouquet W Boterberg T Ceelen W In vitro cytotoxicity of paclitaxel/β-cyclodextrin complexes for HIPEC Int J Pharm 2009 367 148 154 18938234 

  21. 21 Hamada H Ishihara K Masuoka N Mikuni K Nakajima N Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins J Biosci Bioeng 2006 102 369 371 17116587 

  22. 22 Bouquet W Ceelen W Fritzinger B Paclitaxel/β-cyclodextrin complexes for hyperthermic peritoneal perfusion – formulation and stability Eur J Pharm Biopharm 2007 66 391 397 17240125 

  23. 23 Liu J Meisner D Kwong E Wu XY Johnston MR A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA–paclitaxel microspheres Biomaterials 2007 28 3236 3244 17434581 

  24. 24 Jackson JK Hung T Letchford K Burt HM The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers Int J Pharm 2007 342 6 17 17555895 

  25. 25 Fang L Jianing L Xuejun W Anti-tumor activity of paclitaxel-loaded chitosan nanoparticles: an in vitro study Mater Sci Eng C Biomim Mater Sens Syst 2009 29 2392 2397 

  26. 26 Danhier F Lecouturier N Vroman B Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation J Control Release 2009 133 11 17 18950666 

  27. 27 Fan L Hong W Hui Z Antitumor drug Paclitaxel-loaded pH-sensitive nanoparticles targeting tumor extracellular pH Carbohydr Polym 2009 77 773 778 

  28. 28 Lee MK Lim SJ Kim CK Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles Biomaterials 2007 28 2137 2146 17257668 

  29. 29 Pulkkinen M Pikkarainen J Wirth T Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin–biotin technology: formulation development and in vitro anticancer activity Eur J Pharm Biophar 2008 70 66 74 

  30. 30 Letchford K Liggins R Wasan KM Burt H In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles Eur J Pharm Biopharm 2009 71 196 206 18762253 

  31. 31 Dong X Mattingly CA Tseng M Cho M Adams VR Mumper RJ Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization Eur J Pharm Biopharm 2009 72 9 17 19111929 

  32. 32 Lim Soo P Cho J Grant J Ho E Piquette-Miller M Allen C Drug release mechanism of paclitaxel from a chitosan–lipid implant system: effect of swelling, degradation and morphology Eur J Pharm Biopharm 2008 69 149 157 18164931 

  33. 33 Kraitzer A Ofek L Schreiber R Zilberman M Long-term in vitro study of paclitaxel-eluting bioresorbable core/shell fiber structures J Control Release 2008 126 139 148 18201789 

  34. 34 Shikanov A Shikanov S Vaisman B Golenser J Domb AJ Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant Int J Pharm 2008 358 114 120 18406086 

  35. 35 LaiYeng L Sudhir HR Yilong F Paclitaxel release from microporous PLGA disks Chem Eng Sci 2009 64 4341 4349 

  36. 36 Guo DD Xu CX Quan JS Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo Biomaterials 2009 30 4777 4785 19524293 

  37. 37 Chun C Lee SM Kim SY Yang HK Song SC Thermosensitive poly(organophosphazene)–paclitaxel conjugate gels for antitumor applications Biomaterials 2009 30 2349 2360 19178941 

  38. 38 Elstad NL Fowers KD OncoGel (ReGel/paclitaxel) – clinical applications for a novel paclitaxel delivery system Adv Drug Deliv Rev 2009 61 785 794 19422870 

  39. 39 Liaw J Lin Y Evaluation of poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide) (PEO–PPO–PEO) gels as a release vehicle for percutaneous fentanyl J Control Release 2000 68 273 282 10925135 

  40. 40 Yang Y Wang J Zhang X Lu W Zhang Q A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel J Control Release 2009 135 175 182 19331864 

  41. 41 Sharma PK Reilly MJ Jones DN Robinson PM Bhatia SR The effect of pharmaceuticals on the nanoscale structure of PEO–PPO–PEO micelles Colloids Surf 2008 61 53 60 

  42. 42 Guzmán M García FF Molpeceres J Polyoxyethylene- polyoxypropylene block copolymer gels as sustained release vehicles for subcutaneous drug administration Int J Pharm 1992 80 119 127 

  43. 43 Barichello JM Morishita M Takayama K Nagai T Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats Int J Pharm 1999 184 189 198 10387948 

  44. 44 Amiji MM Lai PK Shenoy DB Rao M Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation Pharm Dev Techno 2002 7 195 202 

  45. 45 Dhanikula AB Singh DR Panchagnula R In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of paclitaxel: gel, film, prodrug, liposomes and micelles Current Drug Deliv 2005 2 35 44 

  46. 46 Dhanikula AB Panchagnula R Preparation and characterization of water-soluble prodrug, liposomes and micelles of paclitaxel Current Drug Deliv 2005 2 75 91 

  47. 47 Dhanikula RS Dhanikula AB Panchagnula R Thermoreversible liposomal poloxamer gel for the delivery of paclitaxel: dose proportionality and hematological toxicity studies Pharmazie 2008 63 439 445 18604987 

  48. 48 Soga O van Nostrum CF Fens M Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery J Control Release 2005 103 341 353 15763618 

  49. 49 Yang Y Wang J Zhang X Lu W Zhang Q A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel J Control Release 2009 135 175 182 19331864 

  50. 50 Korsemeyer RW Gurney R Doelker E Mechanisms of solute release from porous hydrophilic polymers Int J Pharm 1983 15 25 35 

  51. 51 Ahuja N Katare OP Singh B Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers Eur J Pharm Biopharm 2007 65 26 38 16962750 

  52. 52 Quinten T de Beer T Vervaet C Remon JP Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets Eur J Pharm Biopharm 2009 71 145 154 18511248 

  53. 53 Peppas NA Sahlin JJ A simple equation for the description of solute release. III. Coupling of diffusion and relaxation Int J Pharm 1989 57 169 172 

  54. 54 Kim H Fassihi R A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. Diltiazem hydrochloride Pharm Res 1997 14 1415 1421 9358555 

  55. 55 Bettini R Colombo PG Massimo PL Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects Eur J Pharm Sci 1994 2 213 219 

  56. 56 Siepmann J Peppas NA Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) Adv Drug Deliv Rev 2001 48 139 157 11369079 

  57. 57 Liu Y Lu WL Wang JC Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic ® F127 hydrogel for subcutaneous administration: in vitro and in vivo characterization J Control Release 2007 117 387 395 17207884 

  58. 58 Johnston TP Punjabi MA Froelich CJ Sustained delivery of interleukin- 2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice Pharm Res 1992 9 425 434 1614979 

  59. 59 Zhang L Parsons DL Navarre C Kompella UB Development and in vitro evaluation of sustained release poloxamer 407(P407) gel formulations of ceftiofur J Control Release 2002 85 73 81 12480313 

  60. 60 Bochot A Fattal E Gulik A Couarraze G Couvreur P Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides Pharm Res 1998 15 1364 1369 9755886 

  61. 61 Pandit NK Wang D Salt effects on the diffusion and release rate of propranolol from poloxamer 407 gels Int J Pharm 1998 167 183 189 

  62. 62 Veyries ML Couarraze G Geiger S Controlled release of vancomycin from poloxamer 407 gels Int J Pharm 1999 192 183 193 10567749 

  63. 63 Matthew JE Nazario YL Roberts SC Bhatia SR Effect of mammalian cell culture medium on the gelation properties of Pluronic F127 Biomaterials 2002 23 4615 4619 12322983 

  64. 64 Shishido SM Seabra AB Loh W Ganzarolli de Oliveira M Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release Biomaterials 2003 24 3543 3553 12809783 

  65. 65 Cabana A Aït-Kadi A Juhász J Study of the gelation process of polyethylene oxidea-polypropylene oxideb-polyethylene oxidea copolymer J Colloid Interface Sci 1997 190 307 312 9241171 

  66. 66 Desai PR Jain NJ Sharma RK Effect of additives on the micellization of PEO/PPO/PEO block copolymer PF127 in aqueous solution Colloids Surf A Physicochem Eng Asp 2001 178 57 69 

  67. 67 Pandit NK Kisaka J Loss of gelation ability of Pluronic ® F127 in the presence of some salts Int J Pharm 1996 145 129 136 

  68. 68 Sharma PK Matthew JE Bhatia SR Structure and assembly of PEO– PPO–PEO co-polymers in mammalian cell-culture media J Biomater Sci Polym Ed 2005 16 1139 1151 16231604 

  69. 69 Wanka G Hoffmann H Ulbricht W Phase diagrams and aggregation behavior of poly(oxyethylene)–poly(oxypropylene)–poly(oxyethylene) triblock copolymes in aqueous solutions Macromolecules 1994 27 4145 4159 

  70. 70 Goldstein RE On the theory of lower critical solution pointing hydrogen- bonded mixtures J Chem Phys 1984 80 53 40 

  71. 71 Bonacucina G Spina M Misici-Falzi M Effect of hydroxypropyl β-cyclodextrin on the self-assembling and thermogelation properties of Poloxamer 407 Eur J Pharm Sci 2007 32 115 122 17656076 

  72. 72 Lin JJ Chen JS Huang SJ Folic acid–Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications Biomaterials 2009 30 5114 5124 19560199 

  73. 73 Batrakova EV Kabanov AV Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J Control Release 2008 130 98 106 18534704 

  74. 74 Wells J Sen A Hui SW Localized delivery to CT-26 tumors in mice using thermosensitive liposomes Int J Pharm 2003 261 105 114 12878399 

  75. 75 Exner AA Krupka TM Scherrer K Teets JM Enhancement of carboplatin toxicity by Pluronic block copolymers J Control Release 2005 106 188 197 15951044 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로